Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Sep;181(3):604-606.
doi: 10.1111/bjd.17779. Epub 2019 May 14.

Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition

M Napolitano  1 , M Megna  2 , G Fabbrocini  2 , S P Nisticò  3 , N Balato  2 , S Dastoli  3 , C Patruno  3
Affiliations
Case Reports

Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition

M Napolitano et al. Br J Dermatol. 2019 Sep.
No abstract available

PubMed Disclaimer

References

    1. Megna M, Balato A, Napolitano M et al. Psoriatic disease treatment nowadays: unmet needs among the “jungle of biologic drugs and small molecules”. Clin Rheumatol 2018; 37:1739-41.
    1. Darrigade AS, Milpied B, Truchetet ME et al. Pattern and severity of psoriasiform eruptions in patients with inflammatory bowel diseases, arthritis or skin inflammatory disorders treated with TNF-alpha inhibitors. Acta DermVenereol 2017; 97:731-4.
    1. Nakamura M, Lee K, Singh R et al. Eczema as an adverse effect of anti-TNFα therapy in psoriasis and other Th1-mediated diseases: a review. J Dermatolog Treat 2017; 28:237-41.
    1. Pernet C, Guillot B, Bessis D. Eczematous drug eruption after ustekinumab treatment. Arch Dermatol 2012; 148:959-60.
    1. Burlando M, Cozzani E, Russo R, Parodi A. Atopic-like dermatitis after secukinumab injection: a case report. Dermatol Ther 2018; 20:e12751.